In this webinar, our PrimeVigilance expert speakers Dr. Marcela Fialova and Dr. Jana Hyankova will aim to present and provide our listeners with a good understanding of Brexit’s impact on EU and UK pharmacovigilance processes, highlighting the challenges for the Pharmaceutical Industry and the critical requirements that could arise.
In this webinar, our PrimeVigilance expert speakers Dr. Marcela Fialova and Dr. Jana Hyankova will aim to present and provide our listeners with a good understanding of Brexit’s impact on EU and UK pharmacovigilance processes, highlighting the challenges for the Pharmaceutical Industry and the critical requirements that could arise.
Key learnings include:
Overview of the new pharmacovigilance post Brexit regulation
• What are the applicable impacts within the EU for the global pharma company
• UK QPPV
• UK PSMF
• PV Procedures
• Submission
• Registering to make submissions to MHRA
• How to maintain consistency
if you have any questions about PrimeVigilance or wish to speak with our experts please reach out to us via marketing@primevigilance.com
